| Source Date | Board Meeting Date | Details |
|
08-Apr-2024
|
16-Apr-2024
|
Inter alia, to consider and approve :- (1) to allot and issue 2600000 equity shares upon conversion of 2600000 warrants to Ipca Laboratories Limited.
|
|
31-Jan-2024
|
08-Feb-2024
|
Quarterly Results
|
|
20-Oct-2023
|
02-Nov-2023
|
Quarterly Results
|
|
26-Jul-2023
|
02-Aug-2023
|
Quarterly Results
|
|
16-May-2023
|
23-May-2023
|
Audited Results
|
|
11-Apr-2023
|
18-Apr-2023
|
Inter alia: to allot and issue 24,00,000 Equity Shares upon conversion of 24,00,000 Warrants to Ipca Laboratories Limited, part of a ?Promoter Group?.
|
|
08-Mar-2023
|
15-Mar-2023
|
Preferential Issue of shares & Issue Of Warrants Inter alia: to allot and issue 20,00,000 Equity Shares and 50,00,000 Warrants convertible into Equity Shares to Ipca Laboratories Limited and to approve draft of Postal Ballot Notice for seeking approval of shareholders for Re-appointment of Mr. Yogesh Shah as an Executive Director.
|
|
31-Jan-2023
|
07-Feb-2023
|
Quarterly Results
|
|
18-Jan-2023
|
21-Jan-2023
|
Issue Of Warrants & Preferential Issue of shares Inter alia to consider and evaluate proposal for raising of funds by way of issue of equity shares or any other eligible convertible securities, through permissible modes or combination of both, subject to all such regulatory/ statutory approvals as may be required including the approval of shareholders of the Company.
|
|
01-Nov-2022
|
09-Nov-2022
|
Quarterly Results
|